Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients

BackgroundChronic spontaneous urticaria (CSU) is a highly prevalent and difficult to manage cutaneous disease characterized by the presence of recurrent urticaria, angioedema, or both, for a period of 6 weeks or longer. One of the biological treatments used for patients with CSU with an autoimmune b...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Cristina López, Nathalie Depreux, Isabel Bielsa, Albert Roger, Bibiana Quirant-Sanchez, Maria Basagaña, Yanina Jurgens, Clara Padró, Sira Miquel, Eva Martinez-Caceres, Aina Teniente-Serra
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	chronic urticaria autoimmune chronic urticaria immune profile omalizumab immune system
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1413233/full